Overview
Naoko Minatani practices practicing medicine in Sagamihara, Japan.
Her clinical expertise encompasses HER2 Negative Breast Cancer and Breast Cancer.
She is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Naoko Minatani
Is Naoko Minatani a top-rated expert for HER2 Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Naoko Minatani is classified as an Experienced expert for HER2 Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Naoko Minatani participate in research or clinical trials?
Yes. Naoko Minatani has published 16 articles and abstracts on conditions like HER2 Negative Breast Cancer. You can view a list of Naoko Minatani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMs. Minatani isExperienced. Learn about Breast Cancer.
- HER2 Negative Breast CancerMs. Minatani isExperienced. Learn about HER2 Negative Breast Cancer.